Close

Rating History for CytomX Therapeutics (CTMX) by Barclays

More Stocks Rated by Barclays | Latest Ratings for CTMX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/7/2022 Peter Lawson Maintain Overweight
(N/A)		 3.50
(7.00)		  
 		   Details